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Results:A 2187bp gene fragment was obtained and coloned
into pMD18-T vector, and the sequence was correct.
hHGF gene was subcloned into pcDNA3.0 vector, and
then restriction endonucleases assays showed the correct
orientation. At the different time point post the ﬁrst
hydrodynamic injection, the expression of hHGF could be
detected by ELISA.
Conclusion: hHGF expression vector (pCMV-hHGF) has
been successfully constructed and repeated hydrodynamic
injections can promote sustained and high expression of
hHGF in vivo.
Supported by the the Science and Technology Foundation of
Anhui Province (No. 07010302195).
OL-021 The difference in serum TNF-alpha and
hepatocyte apoptosis between rats with acute
liver failure and acute-on-chronic liver failure
X.H. Liu1 *, Y. Chen1, Z.P. Duan1, L.J. Zhang1, T.L. Wang2.
1Beijing Youan Hospital, Capital Medical University, China,
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Background: Tumor necrosis factor (TNF) a plays a pivotal
role in pathogenesis of D-Galactosamine (D-Gal) and
lipopolysaccharide (LPS)-induced liver injury.The present
study was designed to investigate changes of serum TNF-a
and hepatocyte apoptosis in D-Gal/LPS induced acute-on-
chronic liver failure (ACLF) and acute liver failure (ALF).
Method: Sixty-ﬁve rats with immunologic hepatic ﬁbrosis
acted as ACLF group, and 50 healthy female Wistar rats
as AHF group. D-Gal (400mg/kg) and LPS (100mg/kg) were
intraperitoneally administered in the two groups. Ten rats
in ACLF group and 6 rats in AHF group were sacriﬁced at 0,
4, 8, and 12 hours, respectively. Blood were taken for liver
function tests and TNF-a levels. Cell apoptosis was detected
by tunnel assay. Mortality and survival time were recorded
in the two groups.
Results: Mortality rates were 88.0% and 58.3%, respectively,
in rats with ACLF and acute liver failure (P= 0.028), with
mean survival time of 15.6 ± 1.8 hours, and 16.1 ±
3.7 hours, respectively. Histology of liver section revealed
massive or submassive necrosis in regenerative nodules,
while ﬁbrosis septa were intact in ACLF rats. Compared
with those in group of acute liver failure, plasma TNF-a
levels were signiﬁcantly lower and arrived its peak later.
Index of apoptosis was signiﬁcantly higher in ACLF group at
each time points than group of acute liver failure.
Conclusion: Animal model of acute-on-chronic liver failure
can be established by treatment human serum albumin-
induced rat’s cirrhosis with D-gal/LPS. When cirrhosis and
healthy rats suffered from acute liver attack, there were
difference in inﬂammatory reaction, extent of cell apoptosis
and changes of subcellular structure.
OL-022 Alpha fetoprotein functions as an inhibitor on
the transduction of caspase-3 signaling pathway
in human hepatoma Bel 7402 cells
M.S. Li1,2 *, S. Zhou1, X.H. Liu2, G. Li2. 1Department of
Biochemistry, Hainan Medical College, Haikou 571101,
China, 2Department of Biochemistry and Molecular Biology,
Peking University Health Science Center, Beijing 100083,
China
Objective: Many evidences indicate that infected with
hepatitis virus B or C concomitants the high expression
of alpha-fetoprotein (AFP) in hepatic cells, AFP is a
tumor marker of hepatoma, documents indicated that AFP
has a property to maintain the growth of hepetocellular
cancinoma cells (HCC) in vivo, but the critical functional
step of AFP still obscurity, the present investigation in order
to explore the inﬂuence AFP on the transduction of apoptotic
signal in HCC and the role mechanism of AFP counteracts the
apoptosis induced of HCC by tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL).
Methods: Laser confocal microscopy was used to observe
co-localization of AFP and caspase-3 or AFP and caspase-8;
Co-immunoprecipitation (Co-IP) was utilized to analyze AFP
interacted with intracellular apoptotic signal molecules
caspase-3 or caspase-8; Short small RNA interfering (siRNA)
was applied to knockdown the expression of AFP in Bel
7402 cells; AFP inﬂuences the activity of caspase-3 or
caspase-8 was detected by protease activity colorimetric
methods; MTT was utilized to analyze the growth and
ﬂuorescent microscopy was used to observe the apoptosis
of Bel 7402 cells after knockdown the expression of AFP
followed treatment with TRAIL (2 nmol/L) for 24 h.
Results: It showed that AFP has a property to interact
with caspase-3 in cytoplasm, but could not binding with
caspase-8; The activity of caspase-3 or caspase-8 was
enhanced when treated with ATRA (40mmol/L) plus TRAIL
(2nmol/L) for 24 h, but treated with TRAIL (2 nmol/L) alone
for 24 h, the activity of caspase-8 was promoted but the
activity of caspase-3 has not any alteration; AFP was able
to inhibit the activity of caspase-3 but it has any affect
on the activity of caspase-8 in vitro; When knockdown the
expression of AFP by RNAi followed treatment with TRAIL
2nmol/L) for 24 h, the activity of caspase-3 was increased
but the activity of caspase-8 had not any change, MTT
detecting showed that the growth of Bel 7402 cells was
inhibited (ratio 48.4%), and TRAIL (2 nmol/L) could induce
the apoptosis of the cancer cells.
Conclusions: AFP has a capacity to block the transduction of
apoptotic signal attribute to it has a property to inhibit the
activity of caspase-3, this is also the pivotal events that AFP
counteracts the apoptosis-induced by TRAIL of hepatoma
cells.
OL-023 Effect of Biﬁdabacterium and Lactobacillus on
endotoxemia in rats with ischemia/reperfusion
liver injury
H.C. Xing1 *, L.J. Li2, K.J. Xu3, Y.B. Chen3, J.G. Wang3.
1Center of Liver Diseases, Beijing Ditan Hospital, Beijing,
100011, China, 2Key Laboratory of Infectious Disease,
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Afﬁliated Hospital, College of Medicine, Zhejiang
University, Hangzhou 310003, China
Background and Aims: This study was performed to
investigate whether supplement of Biﬁdabacterium and
Lactobacillus could improvement endotoxemia and liver
function in rats with I/R liver injury and the mechanisms
involved.
Methods: Thirty-seven adult Sprague-Dawley in SPF grade
rats (200±10g) were randomized into four groups: including
Group 1 (sham group, n = 6), Group 2 (ischemia/reperfusion
group, n = 10), Group 3 (BIF group, n = 10) and Group 4
(LACT group, n = 11). Rats received Biﬁdobacterium ZYB0401
(1.2×109 cfu/day) or Lactobacillus ZYL0401 (1.2×109
cfu/day) respectively in Group 3, Group 4 respectively,
or physiological saline in Group 1 and Group 2 for a week.
On the sixth day, rats except for in Control or Sham group
were subjected to 20 min of liver ischemia, and rats in Sham
group were only subjected to sham operation. Twenty-two
hours later, rats were sacriﬁced and liver enzymes, plasma
endotoxin, serum tumor necrosis factor-a (TNF-a), intestinal
bacterial count, intestinal mucosal histology was studied.
Results: Plasma endotoxin increased signiﬁcantly in rats
subjected to Ischemia-reperfusion, associated with liver
enzymes elevation (p < 0.01). Intestinal Biﬁdobacterium
and Lactobacillus decreased (p < 0.01) and Intestinal
Enterobacteria and Enterococci (p < 0.05) increased in Model
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group compared to Sham group. Intestinal microvilli were
lost, disrupted and the interspace between cells became
wider in Model group. Pretreatment with Biﬁdobacterium
ZYB0401 or Lactobacillus ZYL0401 increased the counts
of Biﬁdobacterium and Lactobacillus in ileal, markedly
ameliorated intestinal mucosal structure and also decreased
plasma endotoxin, serum TNF-a (p < 0.05).
Conclusion: Pretreatment with Biﬁdobacterium ZYB0401
or Lactobacillus ZYL0401 could improve intestinal mucous
barrier, reduced plasma edotoxin and serum TNF-a levels.
Project supported by the National Basic Research Program
(973) of China (No. 2003CB515506), Postdoctoral Fund of
China (20040350233) and Postdoctoral Fund of Zhejiang
Province.
OL-024 A clinical study on metabolic syndrome in
patients with HCV-related liver cirrhosis
W.Y. Zhang*, X.L. Fan. Beijing Ditan Hospital, Beijing
100011, China
Objective: To explore the incidence of metabolic syndrome
(MS) and its clinical characteristics in patients with HCV-
related liver cirrhosis (LCC) from Beijing.
Methods: The incidence of various metabolic disorders in
104 patients with LCC was studied by checking serum
biochemistry, body mass index (BMI), virus load, colored
ultra sonic and etc. According to their metabolic disorders,
two groups were established: LCC with metabolic syndrome
group (LCC+MS) and LCC without metabolic syndrome group
(LCC-MS).The incidence of metabolic disorders in LCC+MS
patients was compared with that in LCC-MS patients.
Results: The incidence of hyperglycemia, hypertension,
obesity, hypertriglyceridemia, hypercholesteremia and MS
in the LCC patients was 70%, 27%, 25%, 15.96%, 6% and
26.92% respectively. BMI, blood pressure and triglyceride in
LCC+MS patients were signiﬁcantly higher than those in LCC-
MS patients. There was no signiﬁcant difference for blood
glucose, cholesterol and ALT between LCC-MS patients and
LCC+MS patients. Unconditional Logistic regression analysis
revealed that BMI was the independent risk factor affecting
the incidence of MS in LCC patients.
Conclusions: Patients with LCC had higher incidence of
hyperglycemia and obesity. Hypertension, obesity and the
abnormality of triglyceride metabolism probably played
important roles in HCV-related cirrhosis with metabolic
syndrome. BMI was an important factor affecting the
complication of MS in LCC patients.
OL-025 Inﬂuence of pregnancy on the development of
liver cancer in rats
Z.Y. Shao*, J. Xin, X. Zhou, G.D. Xia, K. Wang, F. Li. China
Hepatic cancer predominantly occurs in Males. This is almost
a commonsense to most of us. But the detailed mechanisms
underlying such phenomenon are still not well-known. The
average age of liver cancer patients are about 30 40 years
old. So most female patients have udergone pregnancy at
least one time. Pregnancy is a very important event before
or during the development of liver cancer in females. In this
special period, not only sex hormones secrete in a strange
manner, but also immune system functions in a special
module which is very different from normal. So it is urgent
to investigate the impact of process of pregancy on the
development of hepatic cancer. In this study, 100 female
SD rats are randomly divided into two groups: pregance
group and control group. Rats in both groups are injected IV
Diethylnitrosomine (a chemical carcinogen). In pregnance
group, rats are raised together with male rats in 3:1 ratio
(3 female, 1 male) to make every rats undergo pregnancy.
While in control group, rats are coupled with spermaduct-
ligated male rats. The size and amount of hepatic cancers in
pregnancy group are smaller and less than those in control
group. The survial rate is also signiﬁcantly higer than that in
control group. We conclude that the process of pregnancy
exerts an inhibitory role in the development of chemical
induced hepatic cancer in rats.
Acknowledgement: This project was sponsored by the
National Natural Science Foundation of China. The number
of the grant is 30600727.
OL-026 Expression of TGFb1, TIMP1 in liver cirrhosis
and pathological signiﬁcance
Y. Jiang*. Department of infectious, the Second Afﬁliated
Hospital, Xinjiang Medical University, Urumqi, 830028,
China
Objective: To detect the expression of transforming growth
factor beta 1 (TGFb1), tissue inhibitors of tissue inhibitors
of metalloproteinase-1 (TIMP1) in liver cirrhosis tissues.
Methods: All 52 liver cirrhosis specimens were detected by
immunohistochemistry (S-P).
Results: Proteins of TGFb1 and TIMP1 were detected in all
liver tissues from 52 liver cirrhosis patients, all in cytoplasm
but not nucleus.
Conclusion: TGFb1and TIMP1 may play an important role
in the development of liver cirrhosis, especially they were
tightly correlated with clinical pathologic factors.
OL-027 Increased expression of Rho-Kinase-I,
p-myosin-binding subunit Thr-697 and alpha
smooth muscle actin in rats liver tissues during
hepatic ﬁbrogenesis
C.X. Hu1, H.C. Xing1 *, H.Q. Jiang2. 1Center of Liver
Diseases, Beijing Ditan Hospital, Beijing, 100011, China,
2Department of Gastroenterology, the Second Hospital
of Hebei Medical University, Shijiazhuang 050000, Hebei
Province, China
Objective: To investigate the dynamic expression of Rho-
Kinase-I (ROCK-I), p-myosin-binding subunit (MBS) Thr-697,
alpha smooth muscle actin (a-SMA) and their mRNA, the
changes of actin cytoskeleton in liver tissues during hepatic
ﬁbrogenesis.
Methods: The Sprague Dawley rats were randomly divided
into two groups, i.e., sham operation group and model group
(bile duct ligation to induce hepatic ﬁbrogenesis). Livers
were harvested at 1wk, 2wk, 3wk and 4wk after operation
respectively in model group and 4wk after operation in
sham group. Histopathological changes were evaluated by
hematoxylin and eosin staining and by Masson’s trichrome
method. Proteins of ROCK-I, p-MBS Thr-697 in the livers were
detected by Western blot and their mRNA were measured
by reverse transcription-polymerase chain reaction (RT-
PCR), while the distribution of ROCK-I, a-SMA in the livers
were assessed immunohistochemistry. The changes ofb-actin
cytoskeleton were studied by ﬂuorescence.
Results: With the development of hepatic ﬁbrosis, the
number of cells expressed ROCK-I and a-SMA in liver tissues
increased obviously in model group. They mainly resided in
the cells of portal vein, ﬁber septa, presinusoid and around
the proliferation bile ducts. The positive areas of ROCK-I
and a-SMA In rat livers from model groups at week 1 to
4 were 14.71%±4.01% and 13.62%±1.48%, 20.66%±2.34%
and 23.25%±2.02%, 26.21%±1.74% and 27.92%±1.61%,
32.50%±2.55% and 33.69%±1.99% respectively, which were
larger than those in control group (5.35%±1.30%, 6.22%
±1.56%) respectively, P < 0.05. aExpression of ROCK-I pro-
teins, p-MBS Thr-697 proteins and a-SMAproteins in rat livers
tissues in model groups was increased by 83%, 80% and 48%
at week 1, by 114%, 137% and 87% at week 2, by 196%, 229%
and 149% at week 3, by 233%, 334% and 210% at week 4re-
spectively, compared with that in control group. Both a-SMA
